Get the Stockscreener App
26.32
0.23%
+0.06
After Hours:
26.3299
0.0099
+0.04%
Overview
News
Price History
Option Chain
Why PFE Down?
Discussions
Forecast
Stock Split
Dividend History
Pfizer Inc. Stock (PFE) Forecast
The Pfizer Inc. (PFE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $26.12, representing a -0.77% decrease from the current price of $26.32. The highest analyst price target is $28.01, and the lowest is $24.22.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PFE Price Target
Average 24.74
(-5.99% Downside)
Is Pfizer Inc. (PFE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.36 | Neutral |
| STOCH(9,6) | 35.33 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.3947 | Sell |
| ADX(14) | 14.48 | Neutral |
| William %R | -50.23 | Neutral |
| CCI(14) | 23.54 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
25.95
Buy
|
26.12
Buy
|
| MA20 |
26.59
Sell
|
26.43
Sell
|
| MA50 |
27.06
Sell
|
27.03
Sell
|
| MA100 |
27.66
Sell
|
28.09
Sell
|
| MA200 |
30.65
Sell
|
30.96
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, PFE could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on PFE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.36 indicates that PFE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.33 indicates that PFE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that PFE is oversold. This suggests that PFE price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.48 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 23.54 indicates that PFE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PFE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pfizer Inc. financial reports and earnings history, Pfizer Inc. (PFE) stock could reach $13.20 by 2030, $10.28 by 2040 and $3.7837 by 2050. See the projected annual prices until 2050 of the Pfizer Inc. stock below:
- Pfizer Inc. (PFE) is expected to reach an average price of $10.43 in 2035, with a high prediction of $14.33 and a low estimate of $10.34. This indicates an $-60.38% rise from the last recorded price of $26.32.
- Pfizer Inc. (PFE) stock is projected to chart a bullish course in 2040, with an average price target of $9.1414, representing an $-65.27% surge from its current level. The forecast ranges from a conservative $7.8798 to a sky-high $10.28.
- Our analysts predict Pfizer Inc. (PFE) to jump -95.21% by 2045, soaring from $1.162 to an average price of $1.262, potentially reaching $7.231. While $1.162 is the low estimate, the potential upside is significant.
- Pfizer Inc. (PFE) stock is expected to climb by 2050, reaching an average of $4.839, a $-81.61% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.7837 and $3.6677, respectively, highlighting the market's uncertainty.
Pfizer Inc. Stock (PFE) Year by Year Forecast
Pfizer Inc. Stock (PFE) Price Forecast for 2024
Our forecast for PFE stock price in 2024 now indicates an average price target of $25.20 with a high forecast of $30.44 and a low forecast of $19.96. The average prediction reflects an decrease of -4.26% from the last recorded price of $26.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $27.02 | $24.22 | $28.01 | +2.67% |
| June, 2024 | $27.43 | $25.62 | $28.27 | +4.20% |
| July, 2024 | $29.83 | $27.26 | $30.44 | +13.35% |
| August, 2024 | $25.01 | $24.54 | $30.24 | -4.99% |
| September, 2024 | $21.53 | $19.96 | $25.63 | -18.19% |
| October, 2024 | $22.29 | $21.55 | $23.82 | -15.31% |
| November, 2024 | $22.66 | $20.73 | $22.97 | -13.91% |
| December, 2024 | $23.56 | $22.40 | $25.15 | -10.48% |
Pfizer Inc. Stock (PFE) Price Forecast for 2025
Pfizer Inc. Stock (PFE) is expected to reach an average price of $20.94 in 2025, with a high prediction of $27.40 and a low estimate of $14.47. This indicates an -20.46% fall from the last recorded price of $26.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $24.64 | $23.22 | $25.16 | -6.38% |
| February, 2025 | $25.35 | $24.97 | $25.97 | -3.67% |
| March, 2025 | $24.66 | $23.14 | $27.40 | -6.32% |
| April, 2025 | $21.37 | $19.05 | $24.65 | -18.82% |
| May, 2025 | $19.37 | $14.47 | $21.24 | -26.39% |
| June, 2025 | $24.98 | $18.15 | $25.91 | -5.10% |
| July, 2025 | $24.23 | $23.32 | $25.73 | -7.94% |
| August, 2025 | $20.24 | $19.54 | $25.21 | -23.09% |
| September, 2025 | $23.15 | $18.45 | $23.24 | -12.05% |
| October, 2025 | $24.99 | $23.24 | $26.39 | -5.07% |
| November, 2025 | $23.40 | $22.91 | $26.05 | -11.08% |
| December, 2025 | $23.50 | $22.47 | $24.62 | -10.72% |
Pfizer Inc. Stock (PFE) Price Forecast for 2026
The predicted value for Pfizer Inc. (PFE) in 2026 is set at an average of $30.34. Estimates vary from a peak of $39.82 to a trough of $20.86, indicating an +15.27% surge from the present price of $26.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $22.68 | $21.80 | $26.03 | -13.83% |
| February, 2026 | $24.49 | $22.75 | $29.22 | -6.94% |
| March, 2026 | $24.62 | $23.95 | $30.39 | -6.47% |
| April, 2026 | $23.97 | $23.57 | $25.23 | -8.94% |
| May, 2026 | $21.93 | $21.72 | $25.03 | -16.66% |
| June, 2026 | $23.82 | $20.86 | $23.86 | -9.50% |
| July, 2026 | $26.21 | $23.38 | $26.34 | -0.43% |
| August, 2026 | $27.70 | $25.65 | $28.78 | +5.25% |
| September, 2026 | $26.57 | $26.23 | $28.49 | +0.94% |
| October, 2026 | $27.49 | $26.64 | $27.96 | +4.43% |
| November, 2026 | $36.43 | $27.40 | $36.51 | +38.42% |
| December, 2026 | $34.87 | $33.43 | $39.82 | +32.48% |
Pfizer Inc. Stock (PFE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pfizer Inc. (PFE) is $39.55, with a high forecast of $50.02 and a low forecast of $29.07. This indicates an +50.25% increase from the last price of $26.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $31.09 | $30.51 | $35.53 | +18.11% |
| February, 2027 | $31.30 | $29.07 | $31.46 | +18.91% |
| March, 2027 | $42.23 | $30.73 | $43.17 | +60.44% |
| April, 2027 | $47.78 | $38.68 | $49.73 | +81.52% |
| May, 2027 | $41.17 | $40.85 | $50.02 | +56.43% |
| June, 2027 | $39.23 | $38.14 | $43.07 | +49.05% |
| July, 2027 | $37.17 | $33.88 | $39.24 | +41.21% |
| August, 2027 | $40.17 | $35.00 | $43.87 | +52.63% |
| September, 2027 | $37.74 | $35.79 | $44.96 | +43.39% |
| October, 2027 | $42.65 | $36.15 | $43.66 | +62.03% |
| November, 2027 | $40.42 | $35.08 | $43.35 | +53.58% |
| December, 2027 | $40.62 | $39.25 | $42.79 | +54.33% |
Pfizer Inc. Stock (PFE) Price Forecast for 2028
In 2028, Pfizer Inc. (PFE) is projected to reach an average price of $35.07, with a high projection of $44.24 and a low estimate of $25.89. This indicates an +33.23% rise from the last price of $26.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $38.12 | $36.77 | $41.77 | +44.85% |
| February, 2028 | $36.88 | $34.14 | $38.39 | +40.13% |
| March, 2028 | $31.43 | $31.03 | $37.41 | +19.41% |
| April, 2028 | $35.73 | $30.57 | $36.68 | +35.74% |
| May, 2028 | $39.39 | $35.35 | $39.39 | +49.67% |
| June, 2028 | $41.16 | $38.48 | $44.24 | +56.38% |
| July, 2028 | $33.20 | $33.02 | $41.28 | +26.16% |
| August, 2028 | $32.69 | $32.06 | $33.91 | +24.21% |
| September, 2028 | $28.94 | $28.78 | $32.43 | +9.95% |
| October, 2028 | $30.82 | $28.82 | $31.84 | +17.11% |
| November, 2028 | $27.05 | $26.91 | $30.98 | +2.78% |
| December, 2028 | $28.13 | $25.89 | $29.88 | +6.88% |
Pfizer Inc. Stock (PFE) Price Forecast for 2029
The 2029 price forecast for Pfizer Inc. Stock (PFE) is $20.03 on average, with a high prediction of $30.17 and a low estimate of $9.8935. This represents an -23.89% decrease from the previous price of $26.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $25.38 | $25.20 | $30.17 | -3.55% |
| February, 2029 | $25.98 | $25.41 | $27.71 | -1.28% |
| March, 2029 | $26.37 | $24.59 | $27.18 | +0.19% |
| April, 2029 | $22.76 | $22.57 | $26.95 | -13.51% |
| May, 2029 | $20.79 | $20.62 | $24.22 | -21.00% |
| June, 2029 | $19.69 | $19.24 | $21.62 | -25.19% |
| July, 2029 | $19.08 | $18.58 | $21.01 | -27.53% |
| August, 2029 | $14.38 | $11.12 | $19.17 | -45.35% |
| September, 2029 | $11.51 | $11.38 | $14.50 | -56.27% |
| October, 2029 | $14.00 | $10.37 | $14.17 | -46.81% |
| November, 2029 | $12.65 | $11.48 | $14.90 | -51.92% |
| December, 2029 | $10.73 | $9.8935 | $14.59 | -59.22% |
Pfizer Inc. Stock (PFE) Price Forecast for 2030
Pfizer Inc. Stock (PFE) is expected to reach an average price of $9.7505 in 2030, with a high forecast of $16.31 and a low forecast of $3.1898. This signifies an -62.95% decrease from the last price of $26.32.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $12.14 | $10.19 | $13.20 | -53.86% |
| February, 2030 | $14.64 | $11.38 | $14.84 | -44.38% |
| March, 2030 | $15.71 | $14.01 | $16.31 | -40.31% |
| April, 2030 | $10.07 | $9.5993 | $16.13 | -61.74% |
| May, 2030 | $7.5598 | $5.9571 | $10.49 | -71.28% |
| June, 2030 | $8.3853 | $7.5987 | $9.8826 | -68.14% |
| July, 2030 | $9.1996 | $6.858 | $9.2396 | -65.05% |
| August, 2030 | $9.8101 | $8.7951 | $11.36 | -62.73% |
| September, 2030 | $12.07 | $9.489 | $12.20 | -54.14% |
| October, 2030 | $12.18 | $11.45 | $12.42 | -53.72% |
| November, 2030 | $11.12 | $9.5916 | $13.84 | -57.73% |
| December, 2030 | $4.9248 | $3.1898 | $11.14 | -81.29% |
0.60%
0.31%
Cap:
|
Volume (24h):